Page 132 - Reuters%20/undefined

Nvidia, Broadcom testing chips on Intel manufacturing process: Report

The two tests, which have not been reported previously, indicate the companies are moving closer to determining whether they will commit hundreds of millions of dollars' contract to Intel

Wall Street declines after discouraging February manufacturing data

An ISM survey showed manufacturing was steady in February, but a measure tracking forward-looking new orders contracted to 48.6 last month from 55.1 in January

Pfizer may move outside manufacturing plants to US: CEO amid tariff threats

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on most goods from Mexico and Canada

US manufacturing stable in February, but storm brewing from tariffs

Domestic manufacturers rely heavily on imported raw materials. Trump in his first month in office has issued a raft of tariff orders

Tesla sales down in France, Scandinavia as Elon Musk faces test of brand

A total of 613 new Teslas were registered in Sweden last month, down 42% year-on-year, while registrations in Norway and Denmark each fell by 48% to 917 and 509 cars respectively

Microchip Technology to lay off 2,000 employees amid weak automotive demand

The company expects to incur between $30 million and $40 million of costs related to the layoffs, consisting of cash severance and related restructuring expenses

Govt bond yields unchanged despite April rate cut bets as supply hurts

The benchmark 10-year yield ended at 6.7383%, compared with its previous close of 6.7286%

Safe-haven gold gains amid weak US dollar, Trump's tariff policies

Trump last week threatened China with an extra 10 per cent duty, set to take effect on Tuesday, resulting in a cumulative 20 per cent tariff

Zelenskyy unwilling to end war; he must be forced to make peace: Kremlin

President Vladimir Putin sent tens of thousands of troops into Ukraine in 2022, triggering the biggest confrontation between Russia and the West since the depths of the Cold War

UN rights chief concerned over 'fundamental shift' in US under Trump

Turk's speech to the UN Human Rights Council in Geneva are his strongest remarks so far on the impact of the new US administration's policies

RBI records forward dollar position undermines forex reserves comfort

The RBI's net short dollar position in forwards and futures hit a record high of $77.5 billion in January 2025, as per data released after market hours on Friday

Piyush Goyal heads to US for talks as Trump tariffs loom, say officials

Goyal's visit was sudden, as he departed after cancelling previously scheduled meetings until March 8

UK investigates TikTok, Reddit over children's personal data practices

Social media companies use complex algorithms to prioritise content and keep users engaged

Japan's Seven & i finalising plan for president Isaka to step down

President Ryuichi Isaka will resign and his replacement is almost certain to be director Stephen Dacus

China's factory activity picks on strong supply, demand; PMI rises to 50.8

Factory production accelerated in February from the previous month, while total new orders increased at the quickest pace in three months

Zelenskyy seeks to salvage US ties after explosive meeting in Oval Office

Zelenskyy reiterated that Ukraine would not concede any territory to Russia as part of a peace deal

Asian share markets in tense wait for US tariff news; bitcoin surges

Bitcoin, the world's largest cryptocurrency by market value, shot up more than 11 per cent to $94,110, while ether, the second-largest cryptocurrency, climbed 14 per cent to $2,528

Nato chief Rutte urges Zelenskyy to mend his relationship with Trump

He said he told Zelenskyy that "we really have to respect what President Trump has done so far for Ukraine"

SoftBank Group CEO in talks to borrow $16 billion to invest in AI: Report

The Japanese technology investor might borrow another $8 billion in early 2026

Piramal Enterprises hit with nearly $172 million tax bill for pharma deal

Maharashtra's tax office has contended that the transfer of its pharma business to Piramal Pharma counts as an itemized sale and not a slump sale, the company said